Literature DB >> 30129474

Traditional Chinese medicine for ischaemic stroke.

Tianlong Liu1, Yi Ding1, Aidong Wen1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30129474     DOI： 10.1016/S1474-4422(18)30290-4

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN： 1474-4422            Impact factor:   44.182


× No keyword cloud information.
  7 in total

1.  NeuroProtect, a Candidate Formula From Traditional Chinese Medicine, Attenuates Amyloid-β and Restores Synaptic Structures in APP/PS1 Transgenic Mice.

Authors:  Yan Tan; Xu Wang; Jiani Zhang; Huawei Zhang; Haiyan Li; Tiantian Peng; Weihang Chen; Peng Wei; Zhaoheng Liu; Fang He; Jiao Li; Haimin Ding; Na Li; Zhaoyang Wang; Zhenqiang Zhang; Qian Hua
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

2.  Network Pharmacology-Based Strategy Combined with Molecular Docking and in vitro Validation Study to Explore the Underlying Mechanism of Huo Luo Xiao Ling Dan in Treating Atherosclerosis.

Authors:  Taoli Sun; Wenjuan Quan; Sha Peng; Dongmei Yang; Jiaqin Liu; Chaoping He; Yu Chen; Bo Hu; Qinhui Tuo
Journal:  Drug Des Devel Ther       Date:  2022-05-30       Impact factor: 4.319

3.  Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.

Authors:  Jiafa Wu; Dongping Luo; Shengnan Li
Journal:  Breast Cancer (Dove Med Press)       Date:  2020-12-08

4.  Tanshinone IIA Protects Against Cerebral Ischemia Reperfusion Injury by Regulating Microglial Activation and Polarization via NF-κB Pathway.

Authors:  Zhibing Song; Jingjing Feng; Qian Zhang; Shanshan Deng; Dahai Yu; Yuefan Zhang; Tiejun Li
Journal:  Front Pharmacol       Date:  2021-04-19       Impact factor: 5.810

5.  Protective Effect of An-Gong-Niu-Huang Wan Pre-treatment Against Experimental Cerebral Ischemia Injury via Regulating GSK-3β/HO-1 Pathway.

Authors:  Shiqing Zhang; Xiaoli Jiang; Ying Wang; Kaili Lin; Zhang Zhang; Zhu Zhang; Peili Zhu; Man Ling Ng; Shaogang Qu; Stephen Cho Wing Sze; Ken Kin Lam Yung
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

6.  TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome.

Authors:  Ping Wang; Shuang Wang; Hong Chen; Xiaofang Deng; Luoqi Zhang; Haiyu Xu; Hongjun Yang
Journal:  Front Pharmacol       Date:  2021-07-15       Impact factor: 5.810

7.  Comparative efficacy and acceptability of traditional Chinese medicine for adult major depression: A protocol for network meta-analysis.

Authors:  Yuze Shao; Kai Wang; Zhenyuan Jiang; Xiaowen Yu; Wenrong An; Yue Han; Zhonglin Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-20       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.